As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Ethosuximide Market: By Form: Capsule, Tablet, Syrup; By Application: Hospitals, Drug Stores; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

Global Ethosuximide Market Outlook

The global ethosuximide market is being driven by the growth of the epilepsy drug market, which is expected to grow in the forecast period of 2022-2027 at a CAGR of 4%.

 

Ethosuximide Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to be a Significant Regional Market for Ethosuximide

The global ethosuximide industry is anticipated to witness a healthy growth over the forecast period. North America is expected to emerge as a significant market for ethosuximide in the coming years. There is a high demand for the drug in this region owing to the rising number of patients suffering from seizures. Apart from North America, Europe is expected to hold a substantial share of the global ethosuximide industry. The increased adoption of the drug for various medications in India and China is contributing towards the market growth in the Asia Pacific region. The Middle East and Africa and Latin America are predicted to witness a steady growth.

 

Ethosuximide Market by Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Ethosuximide: Industry Definition and Segmentation

Ethosuximide is a medication used in the treatment of absence seizures. Absence seizures are characterised by a brief, sudden lapse of consciousness. It is commonly sold under the brand name Zarontin.

The major forms of ethosuximide are:

  • Capsule
  • Tablet
  • Syrup

The market can be broadly categorised based on its applications segments into:

  • Hospitals
  • Drug Stores

The EMR report looks into the regional markets of ethosuximide like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Ethosuximide Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Number of Seizure Patients are Driving the Market Growth of Ethosuximide

The global market for ethosuximide is being driven by the increasing number of patients suffering from absence seizures. Absence seizures are a medical disorder characterised by the temporary, sudden lapse in consciousness. Unlike its alternative valproic acid, which contains idiosyncratic hepatoxicity, ethosuximide is considered to be the primary drug for the treatment of absence seizures. The increasing investments in research and development by the government is aiding the market. Increasing health consciousness and improved living standards are expected to boost the market growth further. These factors are anticipated to bolster the global ethosuximide industry over the forecast period of 2022-2027.

 

Key Industry Players in the Global Ethosuximide Market

The report presents a detailed analysis of the following key players in the global ethosuximide market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Pfizer Inc.
  • Akorn, Incorporated
  • Chemwerth, Inc
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Form, Application, Region
Breakup by Form Capsule, Tablet, Syrup
Breakup by Application Hospitals, Drug Stores
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Pfizer Inc., Akorn, Incorporated, Chemwerth, Inc, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Ethosuximide Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Ethosuximide Historical Market (2017-2021) 
    8.3    Global Ethosuximide Market Forecast (2022-2027)
    8.4    Global Ethosuximide Market by Form
        8.4.1    Capsule
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Tablet
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Syrup
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Global Ethosuximide Market by Application
        8.5.1    Hospitals
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Drug Stores
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Ethosuximide Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape
    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Pfizer Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Akorn, Incorporated
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Chemwerth, Inc
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Ethosuximide Market: Key Industry Highlights, 2016 and 2026
2.    Global Ethosuximide Historical Market: Breakup by Form (USD Million), 2017-2021
3.    Global Ethosuximide Market Forecast: Breakup by Form (USD Million), 2022-2027
4.    Global Ethosuximide Historical Market: Breakup by Application (USD Million), 2017-2021
5.    Global Ethosuximide Market Forecast: Breakup by Application (USD Million), 2022-2027
6.    Global Ethosuximide Historical Market: Breakup by Region (USD Million), 2017-2021
7.    Global Ethosuximide Market Forecast: Breakup by Region (USD Million), 2022-2027
8.    North America Ethosuximide Historical Market: Breakup by Country (USD Million), 2017-2021
9.    North America Ethosuximide Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Europe Ethosuximide Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Europe Ethosuximide Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Asia Pacific Ethosuximide Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Asia Pacific Ethosuximide Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Latin America Ethosuximide Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Latin America Ethosuximide Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Middle East and Africa Ethosuximide Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Middle East and Africa Ethosuximide Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Global Ethosuximide Market Structure

Key Questions Answered in the Report

The global ethosuximide market is expected to be driven by the global epilepsy drug market, which is projected to grow at a CAGR of 4% between 2021 and 2026.

The major drivers of the industry, such as rising disposable incomes, growing health consciousness, rapid urbanisation, growing population, and the increasing number of patients affected by absence seizures, are expected to aid the market growth.

The key trends guiding the growth of the industry are the rising product awareness and health consciousness among the consumers.

The major regional markets of ethosuximide are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The major forms of ethosuximide are tablet, capsule, and syrup.

Ethosuximide finds its application in hospitals and drug stores.

The key industry players include Pfizer Inc., Akorn, Incorporated, and Chemwerth, Inc, among others.

Analyst Review

The global ethosuximide market is being driven by the global epilepsy drug market. Aided by the rising health consciousness, the global epilepsy drug market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 4%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its forms, the market can be segmented into capsules, tablets, and syrups. By application, the market is categorised into hospitals and drug stores. The major regional markets for ethosuximide are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., Akorn, Incorporated, and Chemwerth, Inc, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER